We are encouraged by Abbott's stock performance, but discouraged by the moves at Honeywell
Every weekday, the CNBC Investment Club with Jim Cramer publishes Homestretch, a handy evening update, just in time for the…
Abbott Laboratories
How to trade Abbott stock after the nearly $500 million infant formula verdict
Every weekday, the CNBC Investment Club with Jim Cramer hosts a live “Morning Meeting” broadcast at 10:20 a.m. ET. Here's…
A poor earnings report from a competitor is good news for Abbott Labs
Every weekday, the CNBC Investment Club with Jim Cramer hosts a live “Morning Meeting” broadcast at 10:20 a.m. ET. Here’s…
Catalyst Calendar: Here's a Look at the Major Events That Could Drive These 7 Stocks Higher
AI technology stocks have been all the rage on Wall Street. But here are some events that could boost other…
Abbott receives FDA approval for Libre Rio and Lingo
Abbott Chairman and CEO Robert B. Ford delivers a keynote speech at CES 2022 at The Venetian Las Vegas on…
We are increasing our geopolitical coverage and a struggling healthcare stock.
We are expanding our only oil reserve and a disadvantaged medical technology company.
Activist's willingness to buy Abbott rival and look beyond baby formula suits
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
We're buying more shares of this healthcare company amid an overblown sell-off
Shortly after the opening bell, we will purchase 140 shares of Abbott Laboratories at approximately $112. Following the deal, Jim…
Nvidia tramples the bears. Jim Cramer on struggling stocks Starbucks and Abbott
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
It's not too late to buy Abbott stock after Friday's sell-off
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…